Botry-Zen poised to release products

Biotechnology company Botry-Zen is poised to release two products and launch in two overseas markets.

Chief executive John Scandrett told the company's annual meeting in Dunedin yesterday that it planned the first full commercial release of its lead product Botry-Zen to the local market this growing season.

This would be followed with late-season product Armour-Zen.

Both products fight the grape diseases botrytis and sclerotinia.

By May next year, the company plans to commercially release Botry-Zen in Germany and Austria, a year ahead of schedule.